| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
178,600,000 |
| Market
Cap: |
226.82(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.8901 - $1.85 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 7.4 |
| Insider 3/6 Months : 8 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Precigen is a clinical-stage biopharmaceutical company improving gene and cell therapies. Co. is utilizing proprietary technology platforms to develop product candidates designed to diseases in its therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. Co. is developing its clinical programs, including: PRGN-3005, PRGN-3006, and PRGN-3007, which are built on its UltraCAR-T platform; PRGN-2009 and PRGN-2012, which are based on its AdenoVerse immunotherapy platform; and AG019, which is built on its ActoBiotics platform. In addition, Co. has completed a Phase 1 study of INXN-4001, a non-viral triple-effector plasmid DNA, which is built on its UltraVector platform.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
96,686 |
1,592,031 |
13,134,243 |
| Total Buy Value |
$0 |
$136,327 |
$2,615,293 |
$22,822,494 |
| Total People Bought |
0 |
1 |
4 |
8 |
| Total Buy Transactions |
0 |
1 |
6 |
12 |
| Total Shares Sold |
0 |
96,686 |
455,706 |
719,367 |
| Total Sell Value |
$0 |
$136,327 |
$650,097 |
$1,021,712 |
| Total People Sold |
0 |
1 |
6 |
6 |
| Total Sell Transactions |
0 |
1 |
21 |
26 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Ares Trading S.a. |
10% Owner |
– – • |
2021-08-16 |
4 |
AS |
$6.13 |
$38,712 |
D/D |
(6,313) |
21,948,759 |
|
-33% |
|
| Ares Trading S.a. |
10% Owner |
– – • |
2021-08-13 |
4 |
AS |
$6.20 |
$322,368 |
D/D |
(52,031) |
21,955,072 |
|
-33% |
|
| Ares Trading S.a. |
10% Owner |
– – • |
2021-08-12 |
4 |
AS |
$6.11 |
$309,786 |
D/D |
(50,684) |
22,007,103 |
|
-35% |
|
| Ares Trading S.a. |
10% Owner |
– – • |
2021-08-11 |
4 |
AS |
$6.11 |
$1,574,281 |
D/D |
(257,800) |
22,057,787 |
|
-35% |
|
| Ares Trading S.a. |
10% Owner |
– – • |
2021-08-10 |
4 |
AS |
$6.02 |
$1,521,696 |
D/D |
(252,933) |
22,315,587 |
|
-34% |
|
| Ares Trading S.a. |
10% Owner |
– – • |
2021-08-09 |
4 |
AS |
$5.59 |
$316,184 |
D/D |
(56,528) |
22,568,520 |
|
-34% |
|
| Ares Trading S.a. |
10% Owner |
– – • |
2021-08-06 |
4 |
AS |
$5.55 |
$403,245 |
D/D |
(72,700) |
22,625,048 |
|
-32% |
|
| Ares Trading S.a. |
10% Owner |
– – • |
2021-08-05 |
4 |
AS |
$5.50 |
$877,887 |
D/D |
(159,703) |
22,697,748 |
|
-36% |
|
| Ares Trading S.a. |
10% Owner |
– – • |
2021-08-04 |
4 |
AS |
$5.47 |
$140,627 |
D/D |
(25,698) |
22,857,451 |
|
-31% |
|
| Ares Trading S.a. |
10% Owner |
– – • |
2021-08-03 |
4 |
AS |
$5.49 |
$11,536 |
D/D |
(2,100) |
22,883,149 |
|
-30% |
|
| Ares Trading S.a. |
10% Owner |
– – • |
2021-07-29 |
4 |
AS |
$5.69 |
$103,745 |
D/D |
(18,247) |
22,885,249 |
|
-29% |
|
| Ares Trading S.a. |
10% Owner |
– – • |
2021-06-28 |
4 |
AS |
$6.88 |
$170,776 |
D/D |
(24,839) |
22,903,496 |
|
-17% |
|
| Ares Trading S.a. |
10% Owner |
– – • |
2021-06-25 |
4 |
AS |
$6.81 |
$1,229,398 |
D/D |
(180,470) |
22,928,335 |
|
-24% |
|
| Ares Trading S.a. |
10% Owner |
– – • |
2021-06-24 |
4 |
AS |
$6.77 |
$1,209,635 |
D/D |
(178,623) |
23,108,805 |
|
-25% |
|
| Ares Trading S.a. |
10% Owner |
– – • |
2021-06-14 |
4 |
AS |
$7.13 |
$396,007 |
D/D |
(55,541) |
23,287,428 |
|
-34% |
|
| Ares Trading S.a. |
10% Owner |
– – • |
2021-06-11 |
4 |
AS |
$7.57 |
$3,857,531 |
D/D |
(509,467) |
23,342,969 |
|
-34% |
|
| Lambert James Vincent |
Ex. Dir. Fin., PGEN Ther. Inc. |
• – – |
2021-06-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
12,356 |
|
-32% |
|
| Ares Trading S.a. |
10% Owner |
– – • |
2021-06-10 |
4 |
AS |
$7.09 |
$652,557 |
D/D |
(91,991) |
23,852,436 |
|
-32% |
|
| Ares Trading S.a. |
10% Owner |
– – • |
2021-06-09 |
4 |
AS |
$7.22 |
$1,120,615 |
D/D |
(155,227) |
23,944,427 |
|
-35% |
|
| Ares Trading S.a. |
10% Owner |
– – • |
2021-06-08 |
4 |
AS |
$7.15 |
$1,618,138 |
D/D |
(226,256) |
24,099,654 |
|
-35% |
|
| Ares Trading S.a. |
10% Owner |
– – • |
2021-06-07 |
4 |
AS |
$6.97 |
$1,416,717 |
D/D |
(203,233) |
24,325,910 |
|
-35% |
|
| Ares Trading S.a. |
10% Owner |
– – • |
2021-06-04 |
4 |
AS |
$6.66 |
$510,408 |
D/D |
(76,685) |
24,529,143 |
|
-30% |
|
| Kirk Randal J |
Director |
– • • |
2021-06-03 |
4 |
A |
$0.00 |
$0 |
I/I |
566,388 |
989,252 |
|
- |
|
| Ares Trading S.a. |
10% Owner |
– – • |
2021-06-03 |
4 |
AS |
$6.59 |
$553,801 |
D/D |
(83,992) |
24,605,828 |
|
-30% |
|
| Ares Trading S.a. |
10% Owner |
– – • |
2021-06-02 |
4 |
AS |
$6.61 |
$802,660 |
D/D |
(121,400) |
24,689,820 |
|
-30% |
|
689 Records found
|
|
Page 8 of 28 |
|
|
0.02 (1.55%) 
